Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical Ikkou Group CoTSE:3353 -0.86%68 EV-to-EBITDA is 5.29 as of Aug. 27, 2026, which is 18% below its 10-year median of 6.45. GuruFocus rates TSE:3353 with a GF Score™ of 68/100 and a GF Value™ of 円3,602.01 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 471 Conglomerates companies, Medical Ikkou Group Co ranks better than 75.58% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medical Ikkou Group Co's enterprise value is 円15,723 Mil.
Medical Ikkou Group Co's EBITDA for the trailing twelve months (TTM) ended in Feb. 2026 was 円2,972 Mil. Therefore, Medical Ikkou Group Co's EV-to-EBITDA for today is 5.29.
The historical rank and industry rank for Medical Ikkou Group Co's EV-to-EBITDA or its related term are showing as below:
TSE:3353'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.9 Med: 6.45 Max: 14.98
Current: 5.3
During the past 13 years, the highest EV-to-EBITDA of Medical Ikkou Group Co was 14.98. The lowest was 3.90. And the median was 6.45.
TSE:3353's EV-to-EBITDA is ranked better than 75.58% of 471
companies
in the Conglomerates industry
Industry Median: 8.9
vs TSE:3353: 5.30
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Medical Ikkou Group Co (TSE:3353) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medical Ikkou Group Co's PE Ratio (TTM) for today is calculated as:
Medical Ikkou Group Co's share price for today is 円2875.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medical Ikkou Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was 円338.730.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Medical Ikkou Group Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Ikkou Group Co EV-to-EBITDA vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Medical Ikkou Group Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Medical Ikkou Group Co's EV-to-EBITDA falls into.
Medical Ikkou Group Co's current Enterprise Value is 円15,723 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medical Ikkou Group Co's EBITDA for the trailing twelve months (TTM) ended in Feb. 2026 was 円2,972 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Ikkou Group Co (TSE:3353) has a EV-to-EBITDA of 5.29 as of Aug. 27, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medical Ikkou Group Co. This is 18% below median its historical median of 6.45. Over the past decade, Medical Ikkou Group Co's EV-to-EBITDA has ranged from 3.90 to 14.98. According to the industry distribution chart, Medical Ikkou Group Co ranks #115 out of 471 companies in the Conglomerates industry, placing it in the top 24.4%.
Is Medical Ikkou Group Co's EV-to-EBITDA too high?
Medical Ikkou Group Co's current EV-to-EBITDA of 5.29 is 18% below median its 10-year median of 6.45. Over the past 10 years, this metric has ranged from a low of 3.90 to a high of 14.98. The Conglomerates industry median EV-to-EBITDA is 8.90. Medical Ikkou Group Co's value of 5.29 is 40.6% below this industry median. Based on the distribution chart, Medical Ikkou Group Co ranks #115 out of 471 companies in the Conglomerates industry, which is in the top quartile — a strong position relative to peers. Overall, Medical Ikkou Group Co has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Ikkou Group Co's EV-to-EBITDA compare to MMM and HON?
According to the Conglomerates industry distribution chart, Medical Ikkou Group Co ranks #115 out of 471 companies for EV-to-EBITDA. This places Medical Ikkou Group Co in the top 24% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 8.90. Medical Ikkou Group Co's value of 5.29 is 40.6% below this benchmark. Historically, Medical Ikkou Group Co's own EV-to-EBITDA has ranged from 3.90 to 14.98 over the past decade. While the company's 10-year median is 6.45 vs. the industry median of 8.90, Medical Ikkou Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Conglomerates company?
The median EV-to-EBITDA among Conglomerates companies is 8.90, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Ikkou Group Co's current EV-to-EBITDA of 5.29 is 40.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medical Ikkou Group Co. For the Conglomerates industry, the median EV-to-EBITDA is 8.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Ikkou Group Co's current EV-to-EBITDA is 5.29, which is 18% below median its own 10-year median of 6.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Ikkou Group Co stock overvalued right now?
Based on GuruFocus' analysis, Medical Ikkou Group Co (TSE:3353) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,602.01, compared to a current price of 円2,875.00 — trading 20.2% below its estimated fair value. The current EV-to-EBITDA is 5.29, which is 18% below median its 10-year median of 6.45 and 40.6% below the Conglomerates industry median of 8.90. Medical Ikkou Group Co's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Medical Ikkou Group Co (TSE:3353), the current EV-to-EBITDA is 5.29 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Ikkou Group Co (TSE:3353) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Ikkou Group Co stock appears to be undervalued.
The current stock price of 円2,875.00 is trading 20.2% below its estimated GF Value™ of 円3,602.01.
GuruFocus considers Medical Ikkou Group Co to be Modestly Undervalued.
Key valuation signals for TSE:3353:
EV-to-EBITDA: 5.29 (18% below median its 10-year median of 6.45)
GF Value™: 円3,602.01 vs. price of 円2,875.00 (20.2% below fair value)
Industry Position: 40.6% below the Conglomerates median (#115 of 471)
No single metric tells the full story. See the TSE:3353 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.
68GF Score
Get the complete analysis for TSE:3353
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3353 has been successfully added to your 
